Pharmoduct, the solution for automated chemotherapy compounding, is arriving to Australia and New Zealand in 2023. Byron Phillips, Dedalus ANZ’s senior principal for digital healthcare strategy, has released an interview to discussing some of the benefits of our technology: “The promise is a game changer in the oncology workflow, by optimising the cancer drug ordering, preparation and receipting process across the supply chain”, says Mr. Phillips.

Read the full article on the website, or get in touch with us to learn more about Pharmoduct.